Results 181 to 190 of about 189,822 (312)

Hypnotic doses of fazamorexant induced less impairment on balance and cognition than zolpidem in healthy younger and elderly individualse

British Journal of Clinical Pharmacology, EarlyView.
Aims Fazamorexant is a dual orexin receptor antagonist being developed for the treatment of insomnia. This study aims to determine the dose‐exposure‐response relationship of single‐dose fazamorexant vs. zolpidem in young adult and elderly healthy Chinese volunteers. Methods This single‐centre, randomized, double‐blind, double‐dummy, placebo‐ and active‐
Chen Xia, Huang Xingxing, Jin Lu, Wang Ruwei   +3 more
wiley   +1 more source

Student-athletes at risk: faculty voices on gender-based violence and the need for structural change in physical activity and sport sciences programs. [PDF]

Front Sports Act Living
Serra Payeras P, Soler-Prat S, Matus-Castillo C, Hinojosa-Alcalde I.   +3 more
europepmc   +1 more source

International trafficking in women and children [PDF]

, 2002
Vermeulen, Gert
core  

Low‐dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug–drug interaction study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Cannabidiol (CBD), the main non‐intoxicating compound from the cannabis plant, is regularly used by patients with chronic pain who also take analgesics. CBD has previously been shown to inhibit CYP‐mediated drug metabolism. This study aimed to characterize the potential pharmacokinetic interaction of CBD with amitriptyline and tramadol ...
Andriy A. Gorbenko, Titiaan E. Post, Pamela K. Strugala, Erica S. Klaassen, Linda E. Klumpers, Saco J. de Visser, Cristina Sempio, Jost Klawitter, Jules A. A. C. Heuberger, Geert J. Groeneveld   +9 more
wiley   +1 more source

Denial of access to sexual and reproductive health services in Europe: an analysis of cases from the European court of human rights (1976-2023). [PDF]

Reprod Health
Groff E, Steger F.
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

A responsive governance path to health equity: the role of state-led public interest litigation in China. [PDF]

Front Public Health
Qi F, Yu B.
europepmc   +1 more source

CHARACTERISTICS OF SUBJECTS OF ABUSE OF PROCEDURAL RIGHTS IN ADMINISTRATIVE PROCEEDINGS

Law Bulletin, 2023
openaire   +1 more source

Psychological features of dispute content and public acceptance of AI in legal adjudication: evidence for systematic variation beyond individual differences. [PDF]

Front Artif Intell
Fujita M, Watamura E.
europepmc   +1 more source

‘Where are the adults?’: Troubling child‐activism and children's political participation

British Educational Research Journal, EarlyView.
Abstract Children's political participation is a well‐established theme in childhood studies. In this article we offer an original account of child activism that takes into account the entangled and emergent aspect of children as activists. We begin with a historical and a conceptual review, noting the importance of mid‐20th century developments such ...
Sharon Hunter, Claire Cassidy
wiley   +1 more source